Gene-editing technologies for cancer and blood disorders are maturing a little more than a year after the first CRISPR drug was approved.
CRISPR genome-editing grows up: advanced therapies head for the clinic
Posted in biotech/medical, genetics
Posted in biotech/medical, genetics
Gene-editing technologies for cancer and blood disorders are maturing a little more than a year after the first CRISPR drug was approved.